[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f6ahhWzYdlsBoCBxIxNDoGkf--wD9V6196GHHlguId_c":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":34,"rows":41},"Kyunghee University Medical Center",[4],63,false,2,8,30514,0,34,[14,17,20,23,25,27,29,31],{"name":15,"count":16},"Healthy",5,{"name":18,"count":19},"Chronic Kidney Disease",4,{"name":21,"count":22},"Type 2 Diabetes Mellitus",3,{"name":24,"count":22},"Obesity",{"name":26,"count":22},"Inflammatory Bowel Diseases",{"name":28,"count":8},"Lumbar Disc Herniation",{"name":30,"count":8},"Crohn's Disease",{"name":32,"count":8},"Helicobacter Pylori Infection",[],[35,36,37,38,39,40],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[42,78,109,127,145,173,191,209,227,250,276,294,322,340,366,392,410,428,454,480,498,522,564,586,613,631,649,671,694,720,738,773,798,824,850,876,902,920,946,971],{"intervention":43,"totalTrials":8,"cells":44},"Ramosetron",{"EARLY_PHASE1":45,"PHASE1":47,"PHASE2":49,"PHASE3":51,"PHASE4":53,"NA":76},{"trials":46,"activeCount":11},[],{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[55,66],{"nctId":56,"briefTitle":57,"status":58,"phases":59,"primaryCompletion":60,"completion":60,"start":61,"enrollment":62,"conditions":63,"interventions":65},"NCT01427127","Effect of Ramosetron on Bowel Motility After Colorectal Resection","UNKNOWN",[39],"2011-12","2010-12",64,[64],"Postoperative Nausea and Vomiting",[43],{"nctId":67,"briefTitle":68,"status":58,"phases":69,"primaryCompletion":70,"completion":70,"start":71,"enrollment":72,"conditions":73,"interventions":74},"NCT02849483","Effect of Ramosetron on Bowel Motility After Gynecological Surgery",[39],"2017-07","2016-07",88,[64],[43,75],"Normal saline",{"trials":77,"activeCount":11},[],{"intervention":79,"totalTrials":80,"cells":81},"Standard full-volume PEG",1,{"EARLY_PHASE1":82,"PHASE1":84,"PHASE2":86,"PHASE3":88,"PHASE4":90,"NA":107},{"trials":83,"activeCount":11},[],{"trials":85,"activeCount":11},[],{"trials":87,"activeCount":11},[],{"trials":89,"activeCount":11},[],{"trials":91,"activeCount":11},[92],{"nctId":93,"briefTitle":94,"status":95,"phases":96,"primaryCompletion":97,"completion":98,"start":99,"enrollment":100,"conditions":101,"interventions":104},"NCT02290093","Bowel Preparation for Colonoscopy in the Elderly","COMPLETED",[39],"2015-09","2015-12","2014-11",230,[102,103],"Bowel Preparation","Colonoscopy",[79,105,106],"Split-dose full-volume PEG","Split-dose low-volume PEG",{"trials":108,"activeCount":11},[],{"intervention":105,"totalTrials":80,"cells":110},{"EARLY_PHASE1":111,"PHASE1":113,"PHASE2":115,"PHASE3":117,"PHASE4":119,"NA":125},{"trials":112,"activeCount":11},[],{"trials":114,"activeCount":11},[],{"trials":116,"activeCount":11},[],{"trials":118,"activeCount":11},[],{"trials":120,"activeCount":11},[121],{"nctId":93,"briefTitle":94,"status":95,"phases":122,"primaryCompletion":97,"completion":98,"start":99,"enrollment":100,"conditions":123,"interventions":124},[39],[102,103],[79,105,106],{"trials":126,"activeCount":11},[],{"intervention":106,"totalTrials":80,"cells":128},{"EARLY_PHASE1":129,"PHASE1":131,"PHASE2":133,"PHASE3":135,"PHASE4":137,"NA":143},{"trials":130,"activeCount":11},[],{"trials":132,"activeCount":11},[],{"trials":134,"activeCount":11},[],{"trials":136,"activeCount":11},[],{"trials":138,"activeCount":11},[139],{"nctId":93,"briefTitle":94,"status":95,"phases":140,"primaryCompletion":97,"completion":98,"start":99,"enrollment":100,"conditions":141,"interventions":142},[39],[102,103],[79,105,106],{"trials":144,"activeCount":11},[],{"intervention":146,"totalTrials":80,"cells":147},"Probiotics",{"EARLY_PHASE1":148,"PHASE1":150,"PHASE2":152,"PHASE3":154,"PHASE4":156,"NA":171},{"trials":149,"activeCount":11},[],{"trials":151,"activeCount":11},[],{"trials":153,"activeCount":11},[],{"trials":155,"activeCount":11},[],{"trials":157,"activeCount":11},[158],{"nctId":159,"briefTitle":160,"status":58,"phases":161,"primaryCompletion":162,"completion":163,"start":164,"enrollment":165,"conditions":166,"interventions":167},"NCT03220542","The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori",[39],"2018-12-31","2019-12-31","2016-01",360,[32],[146,168,169,170],"Esomeprazole","Amoxicillin","Clarithromycin",{"trials":172,"activeCount":11},[],{"intervention":168,"totalTrials":80,"cells":174},{"EARLY_PHASE1":175,"PHASE1":177,"PHASE2":179,"PHASE3":181,"PHASE4":183,"NA":189},{"trials":176,"activeCount":11},[],{"trials":178,"activeCount":11},[],{"trials":180,"activeCount":11},[],{"trials":182,"activeCount":11},[],{"trials":184,"activeCount":11},[185],{"nctId":159,"briefTitle":160,"status":58,"phases":186,"primaryCompletion":162,"completion":163,"start":164,"enrollment":165,"conditions":187,"interventions":188},[39],[32],[146,168,169,170],{"trials":190,"activeCount":11},[],{"intervention":169,"totalTrials":80,"cells":192},{"EARLY_PHASE1":193,"PHASE1":195,"PHASE2":197,"PHASE3":199,"PHASE4":201,"NA":207},{"trials":194,"activeCount":11},[],{"trials":196,"activeCount":11},[],{"trials":198,"activeCount":11},[],{"trials":200,"activeCount":11},[],{"trials":202,"activeCount":11},[203],{"nctId":159,"briefTitle":160,"status":58,"phases":204,"primaryCompletion":162,"completion":163,"start":164,"enrollment":165,"conditions":205,"interventions":206},[39],[32],[146,168,169,170],{"trials":208,"activeCount":11},[],{"intervention":170,"totalTrials":80,"cells":210},{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":219,"NA":225},{"trials":212,"activeCount":11},[],{"trials":214,"activeCount":11},[],{"trials":216,"activeCount":11},[],{"trials":218,"activeCount":11},[],{"trials":220,"activeCount":11},[221],{"nctId":159,"briefTitle":160,"status":58,"phases":222,"primaryCompletion":162,"completion":163,"start":164,"enrollment":165,"conditions":223,"interventions":224},[39],[32],[146,168,169,170],{"trials":226,"activeCount":11},[],{"intervention":228,"totalTrials":80,"cells":229},"23-valent polysaccharide pneumococcal vaccine",{"EARLY_PHASE1":230,"PHASE1":232,"PHASE2":234,"PHASE3":236,"PHASE4":238,"NA":248},{"trials":231,"activeCount":11},[],{"trials":233,"activeCount":11},[],{"trials":235,"activeCount":11},[],{"trials":237,"activeCount":11},[],{"trials":239,"activeCount":11},[240],{"nctId":241,"briefTitle":242,"status":95,"phases":243,"primaryCompletion":244,"completion":244,"start":60,"enrollment":245,"conditions":246,"interventions":247},"NCT01505855","Efficacy Study of Pneumococcal Vaccination in Crohn's Disease",[39],"2013-06",197,[30],[228],{"trials":249,"activeCount":11},[],{"intervention":251,"totalTrials":80,"cells":252},"NESINA ACT TAB. 25\u002F15mg",{"EARLY_PHASE1":253,"PHASE1":255,"PHASE2":257,"PHASE3":259,"PHASE4":261,"NA":274},{"trials":254,"activeCount":11},[],{"trials":256,"activeCount":11},[],{"trials":258,"activeCount":11},[],{"trials":260,"activeCount":11},[],{"trials":262,"activeCount":11},[263],{"nctId":264,"briefTitle":265,"status":58,"phases":266,"primaryCompletion":267,"completion":268,"start":70,"enrollment":269,"conditions":270,"interventions":272},"NCT02823808","Effect of Alogliptin\u002FPioglitazone on the Preservation of Long-term Beta-cell Function",[39],"2021-07","2021-12",96,[271],"Diabetes",[251,273],"AMARYL-M TAB. 2\u002F500mg",{"trials":275,"activeCount":11},[],{"intervention":273,"totalTrials":80,"cells":277},{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":286,"NA":292},{"trials":279,"activeCount":11},[],{"trials":281,"activeCount":11},[],{"trials":283,"activeCount":11},[],{"trials":285,"activeCount":11},[],{"trials":287,"activeCount":11},[288],{"nctId":264,"briefTitle":265,"status":58,"phases":289,"primaryCompletion":267,"completion":268,"start":70,"enrollment":269,"conditions":290,"interventions":291},[39],[271],[251,273],{"trials":293,"activeCount":11},[],{"intervention":295,"totalTrials":80,"cells":296},"intensive insulin group",{"EARLY_PHASE1":297,"PHASE1":299,"PHASE2":301,"PHASE3":303,"PHASE4":305,"NA":320},{"trials":298,"activeCount":11},[],{"trials":300,"activeCount":11},[],{"trials":302,"activeCount":11},[],{"trials":304,"activeCount":11},[],{"trials":306,"activeCount":11},[307],{"nctId":308,"briefTitle":309,"status":95,"phases":310,"primaryCompletion":311,"completion":312,"start":313,"enrollment":314,"conditions":315,"interventions":318},"NCT00474838","Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy",[39],"2012-08","2012-12","2007-04",112,[21,316,317],"Pancreatic Beta Cell Function","Glucotoxicity",[295,319],"Oral AntiDiabetic Drug",{"trials":321,"activeCount":11},[],{"intervention":319,"totalTrials":80,"cells":323},{"EARLY_PHASE1":324,"PHASE1":326,"PHASE2":328,"PHASE3":330,"PHASE4":332,"NA":338},{"trials":325,"activeCount":11},[],{"trials":327,"activeCount":11},[],{"trials":329,"activeCount":11},[],{"trials":331,"activeCount":11},[],{"trials":333,"activeCount":11},[334],{"nctId":308,"briefTitle":309,"status":95,"phases":335,"primaryCompletion":311,"completion":312,"start":313,"enrollment":314,"conditions":336,"interventions":337},[39],[21,316,317],[295,319],{"trials":339,"activeCount":11},[],{"intervention":341,"totalTrials":80,"cells":342},"Onion peel extract",{"EARLY_PHASE1":343,"PHASE1":345,"PHASE2":347,"PHASE3":349,"PHASE4":351,"NA":364},{"trials":344,"activeCount":11},[],{"trials":346,"activeCount":11},[],{"trials":348,"activeCount":11},[],{"trials":350,"activeCount":11},[],{"trials":352,"activeCount":11},[353],{"nctId":354,"briefTitle":355,"status":95,"phases":356,"primaryCompletion":357,"completion":357,"start":358,"enrollment":359,"conditions":360,"interventions":363},"NCT02180022","Effects of Onion Peel Extract on Endothelial Function",[39],"2013-12","2013-04",62,[15,361,362],"Overweight","Obese",[341],{"trials":365,"activeCount":11},[],{"intervention":367,"totalTrials":80,"cells":368},"Oxycodone",{"EARLY_PHASE1":369,"PHASE1":371,"PHASE2":373,"PHASE3":375,"PHASE4":377,"NA":390},{"trials":370,"activeCount":11},[],{"trials":372,"activeCount":11},[],{"trials":374,"activeCount":11},[],{"trials":376,"activeCount":11},[],{"trials":378,"activeCount":11},[379],{"nctId":380,"briefTitle":381,"status":58,"phases":382,"primaryCompletion":383,"completion":383,"start":384,"enrollment":385,"conditions":386,"interventions":388},"NCT03019562","Oxycodone vs. Fentanyl in Early Postoperative Pain After Total Hip Replacement",[39],"2017-12","2016-12",46,[387],"Pain, Postoperative",[367,389],"Fentanyl",{"trials":391,"activeCount":11},[],{"intervention":389,"totalTrials":80,"cells":393},{"EARLY_PHASE1":394,"PHASE1":396,"PHASE2":398,"PHASE3":400,"PHASE4":402,"NA":408},{"trials":395,"activeCount":11},[],{"trials":397,"activeCount":11},[],{"trials":399,"activeCount":11},[],{"trials":401,"activeCount":11},[],{"trials":403,"activeCount":11},[404],{"nctId":380,"briefTitle":381,"status":58,"phases":405,"primaryCompletion":383,"completion":383,"start":384,"enrollment":385,"conditions":406,"interventions":407},[39],[387],[367,389],{"trials":409,"activeCount":11},[],{"intervention":75,"totalTrials":80,"cells":411},{"EARLY_PHASE1":412,"PHASE1":414,"PHASE2":416,"PHASE3":418,"PHASE4":420,"NA":426},{"trials":413,"activeCount":11},[],{"trials":415,"activeCount":11},[],{"trials":417,"activeCount":11},[],{"trials":419,"activeCount":11},[],{"trials":421,"activeCount":11},[422],{"nctId":67,"briefTitle":68,"status":58,"phases":423,"primaryCompletion":70,"completion":70,"start":71,"enrollment":72,"conditions":424,"interventions":425},[39],[64],[43,75],{"trials":427,"activeCount":11},[],{"intervention":429,"totalTrials":80,"cells":430},"Cocktail",{"EARLY_PHASE1":431,"PHASE1":433,"PHASE2":435,"PHASE3":437,"PHASE4":439,"NA":452},{"trials":432,"activeCount":11},[],{"trials":434,"activeCount":11},[],{"trials":436,"activeCount":11},[],{"trials":438,"activeCount":11},[],{"trials":440,"activeCount":11},[441],{"nctId":442,"briefTitle":443,"status":58,"phases":444,"primaryCompletion":445,"completion":446,"start":447,"enrollment":448,"conditions":449,"interventions":451},"NCT06113497","A Prospective Study on the Comparison of Postoperative Pain According to the Use of Cocktail Therapy in Laminoplasty",[39],"2024-10-24","2025-09-30","2023-11-25",60,[450],"Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified",[429],{"trials":453,"activeCount":11},[],{"intervention":455,"totalTrials":80,"cells":456},"exenatide BYETTA®",{"EARLY_PHASE1":457,"PHASE1":459,"PHASE2":461,"PHASE3":463,"PHASE4":465,"NA":478},{"trials":458,"activeCount":11},[],{"trials":460,"activeCount":11},[],{"trials":462,"activeCount":11},[],{"trials":464,"activeCount":11},[],{"trials":466,"activeCount":11},[467],{"nctId":468,"briefTitle":469,"status":95,"phases":470,"primaryCompletion":471,"completion":471,"start":472,"enrollment":473,"conditions":474,"interventions":476},"NCT01580514","Myocardial Protection of Exenatide in AMI",[39],"2011-08","2009-09",127,[475],"Myocardial Infarction",[455,477],"Saline",{"trials":479,"activeCount":11},[],{"intervention":477,"totalTrials":80,"cells":481},{"EARLY_PHASE1":482,"PHASE1":484,"PHASE2":486,"PHASE3":488,"PHASE4":490,"NA":496},{"trials":483,"activeCount":11},[],{"trials":485,"activeCount":11},[],{"trials":487,"activeCount":11},[],{"trials":489,"activeCount":11},[],{"trials":491,"activeCount":11},[492],{"nctId":468,"briefTitle":469,"status":95,"phases":493,"primaryCompletion":471,"completion":471,"start":472,"enrollment":473,"conditions":494,"interventions":495},[39],[475],[455,477],{"trials":497,"activeCount":11},[],{"intervention":499,"totalTrials":80,"cells":500},"Clopidogrel, cilostazol",{"EARLY_PHASE1":501,"PHASE1":503,"PHASE2":505,"PHASE3":507,"PHASE4":509,"NA":520},{"trials":502,"activeCount":11},[],{"trials":504,"activeCount":11},[],{"trials":506,"activeCount":11},[],{"trials":508,"activeCount":11},[],{"trials":510,"activeCount":11},[511],{"nctId":512,"briefTitle":513,"status":95,"phases":514,"primaryCompletion":515,"completion":515,"start":472,"enrollment":516,"conditions":517,"interventions":519},"NCT01328470","Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease",[39],"2010-08",85,[18,518],"Stable Angina",[499],{"trials":521,"activeCount":11},[],{"intervention":523,"totalTrials":22,"cells":524},"Ticagrelor",{"EARLY_PHASE1":525,"PHASE1":527,"PHASE2":529,"PHASE3":531,"PHASE4":560,"NA":562},{"trials":526,"activeCount":11},[],{"trials":528,"activeCount":11},[],{"trials":530,"activeCount":11},[],{"trials":532,"activeCount":11},[533,542,551],{"nctId":534,"briefTitle":535,"status":58,"phases":536,"primaryCompletion":537,"completion":537,"start":472,"enrollment":538,"conditions":539,"interventions":540},"NCT02394145","Genotype and Platelet Reactivity in Patients on Hemodialysis",[38],"2015-08",20,[18],[523,541],"Clopidogrel",{"nctId":543,"briefTitle":544,"status":58,"phases":545,"primaryCompletion":546,"completion":537,"start":547,"enrollment":548,"conditions":549,"interventions":550},"NCT02406911","Ticagrelor and Anti-inflammatory Effects",[38],"2015-06","2015-02",25,[18],[523],{"nctId":552,"briefTitle":553,"status":95,"phases":554,"primaryCompletion":555,"completion":555,"start":556,"enrollment":557,"conditions":558,"interventions":559},"NCT02163954","ONSET and OFFSET of Ticagrelor in ESRD",[38],"2013-08","2013-01",16,[18],[523,541],{"trials":561,"activeCount":11},[],{"trials":563,"activeCount":11},[],{"intervention":541,"totalTrials":8,"cells":565},{"EARLY_PHASE1":566,"PHASE1":568,"PHASE2":570,"PHASE3":572,"PHASE4":582,"NA":584},{"trials":567,"activeCount":11},[],{"trials":569,"activeCount":11},[],{"trials":571,"activeCount":11},[],{"trials":573,"activeCount":11},[574,578],{"nctId":534,"briefTitle":535,"status":58,"phases":575,"primaryCompletion":537,"completion":537,"start":472,"enrollment":538,"conditions":576,"interventions":577},[38],[18],[523,541],{"nctId":552,"briefTitle":553,"status":95,"phases":579,"primaryCompletion":555,"completion":555,"start":556,"enrollment":557,"conditions":580,"interventions":581},[38],[18],[523,541],{"trials":583,"activeCount":11},[],{"trials":585,"activeCount":11},[],{"intervention":587,"totalTrials":80,"cells":588},"dabigatran",{"EARLY_PHASE1":589,"PHASE1":591,"PHASE2":593,"PHASE3":595,"PHASE4":609,"NA":611},{"trials":590,"activeCount":11},[],{"trials":592,"activeCount":11},[],{"trials":594,"activeCount":11},[],{"trials":596,"activeCount":11},[597],{"nctId":598,"briefTitle":599,"status":58,"phases":600,"primaryCompletion":601,"completion":601,"start":602,"enrollment":603,"conditions":604,"interventions":606},"NCT02544932","Pleotropic Effect of New Oral Anticoagulants",[38],"2017-09","2015-10",55,[605],"Atrial Fibrillation",[587,607,608],"ribaroxaban","Warfarin",{"trials":610,"activeCount":11},[],{"trials":612,"activeCount":11},[],{"intervention":607,"totalTrials":80,"cells":614},{"EARLY_PHASE1":615,"PHASE1":617,"PHASE2":619,"PHASE3":621,"PHASE4":627,"NA":629},{"trials":616,"activeCount":11},[],{"trials":618,"activeCount":11},[],{"trials":620,"activeCount":11},[],{"trials":622,"activeCount":11},[623],{"nctId":598,"briefTitle":599,"status":58,"phases":624,"primaryCompletion":601,"completion":601,"start":602,"enrollment":603,"conditions":625,"interventions":626},[38],[605],[587,607,608],{"trials":628,"activeCount":11},[],{"trials":630,"activeCount":11},[],{"intervention":608,"totalTrials":80,"cells":632},{"EARLY_PHASE1":633,"PHASE1":635,"PHASE2":637,"PHASE3":639,"PHASE4":645,"NA":647},{"trials":634,"activeCount":11},[],{"trials":636,"activeCount":11},[],{"trials":638,"activeCount":11},[],{"trials":640,"activeCount":11},[641],{"nctId":598,"briefTitle":599,"status":58,"phases":642,"primaryCompletion":601,"completion":601,"start":602,"enrollment":603,"conditions":643,"interventions":644},[38],[605],[587,607,608],{"trials":646,"activeCount":11},[],{"trials":648,"activeCount":11},[],{"intervention":650,"totalTrials":80,"cells":651},"Sitagliptin",{"EARLY_PHASE1":652,"PHASE1":654,"PHASE2":656,"PHASE3":658,"PHASE4":667,"NA":669},{"trials":653,"activeCount":11},[],{"trials":655,"activeCount":11},[],{"trials":657,"activeCount":11},[],{"trials":659,"activeCount":11},[660],{"nctId":661,"briefTitle":662,"status":58,"phases":663,"primaryCompletion":546,"completion":537,"start":547,"enrollment":664,"conditions":665,"interventions":666},"NCT02406950","Sitagliptin and Endothelial Dysfunction",[38],10,[15],[650],{"trials":668,"activeCount":11},[],{"trials":670,"activeCount":11},[],{"intervention":672,"totalTrials":80,"cells":673},"Euiiyin-tang",{"EARLY_PHASE1":674,"PHASE1":676,"PHASE2":678,"PHASE3":680,"PHASE4":690,"NA":692},{"trials":675,"activeCount":11},[],{"trials":677,"activeCount":11},[],{"trials":679,"activeCount":11},[],{"trials":681,"activeCount":11},[682],{"nctId":683,"briefTitle":684,"status":95,"phases":685,"primaryCompletion":547,"completion":686,"start":358,"enrollment":687,"conditions":688,"interventions":689},"NCT01724099","Evaluating the Safety and Efficacy of Euiiyin-tang on Obesity",[37,38],"2017-06",149,[24],[672],{"trials":691,"activeCount":11},[],{"trials":693,"activeCount":11},[],{"intervention":695,"totalTrials":80,"cells":696},"Bosinji",{"EARLY_PHASE1":697,"PHASE1":699,"PHASE2":701,"PHASE3":703,"PHASE4":716,"NA":718},{"trials":698,"activeCount":11},[],{"trials":700,"activeCount":11},[],{"trials":702,"activeCount":11},[],{"trials":704,"activeCount":11},[705],{"nctId":706,"briefTitle":707,"status":95,"phases":708,"primaryCompletion":709,"completion":710,"start":711,"enrollment":712,"conditions":713,"interventions":714},"NCT03386149","Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine",[38],"2019-12-27","2020-01-22","2017-12-28",74,[28],[695,715],"Loxonine tab.",{"trials":717,"activeCount":11},[],{"trials":719,"activeCount":11},[],{"intervention":715,"totalTrials":80,"cells":721},{"EARLY_PHASE1":722,"PHASE1":724,"PHASE2":726,"PHASE3":728,"PHASE4":734,"NA":736},{"trials":723,"activeCount":11},[],{"trials":725,"activeCount":11},[],{"trials":727,"activeCount":11},[],{"trials":729,"activeCount":11},[730],{"nctId":706,"briefTitle":707,"status":95,"phases":731,"primaryCompletion":709,"completion":710,"start":711,"enrollment":712,"conditions":732,"interventions":733},[38],[28],[695,715],{"trials":735,"activeCount":11},[],{"trials":737,"activeCount":11},[],{"intervention":739,"totalTrials":8,"cells":740},"Loxoprofen",{"EARLY_PHASE1":741,"PHASE1":743,"PHASE2":745,"PHASE3":767,"PHASE4":769,"NA":771},{"trials":742,"activeCount":11},[],{"trials":744,"activeCount":11},[],{"trials":746,"activeCount":11},[747,757],{"nctId":748,"briefTitle":749,"status":95,"phases":750,"primaryCompletion":751,"completion":752,"start":753,"enrollment":448,"conditions":754,"interventions":756},"NCT01922466","East-West Collaboration Treatment Using Bee Venom Acupuncture and NSAIDs for Chronic Cervicalgia",[37],"2014-03","2014-07","2013-07",[755],"Chronic Non-specific, Uncomplicated Neck Pain",[739],{"nctId":758,"briefTitle":759,"status":58,"phases":760,"primaryCompletion":761,"completion":761,"start":762,"enrollment":763,"conditions":764,"interventions":766},"NCT01491321","Bee Venom Acupuncture for the Treatment of Chronic Low Back Pain",[37],"2012-03","2011-04",54,[765],"Chronic Low Back Pain",[739],{"trials":768,"activeCount":11},[],{"trials":770,"activeCount":11},[],{"trials":772,"activeCount":11},[],{"intervention":774,"totalTrials":80,"cells":775},"WIN-34B",{"EARLY_PHASE1":776,"PHASE1":778,"PHASE2":780,"PHASE3":792,"PHASE4":794,"NA":796},{"trials":777,"activeCount":11},[],{"trials":779,"activeCount":11},[],{"trials":781,"activeCount":11},[782],{"nctId":783,"briefTitle":784,"status":95,"phases":785,"primaryCompletion":786,"completion":787,"start":358,"enrollment":788,"conditions":789,"interventions":791},"NCT01873053","A 12 Week, Phase II Trial to Evaluate the Efficacy and Safety of WIN-34B in Patients With Osteoarthritis of the Knee",[37],"2014-04","2014-08",150,[790],"Osteoarthritis, Knee",[774],{"trials":793,"activeCount":11},[],{"trials":795,"activeCount":11},[],{"trials":797,"activeCount":11},[],{"intervention":799,"totalTrials":80,"cells":800},"Combination of SH003 and Docetaxel",{"EARLY_PHASE1":801,"PHASE1":803,"PHASE2":816,"PHASE3":818,"PHASE4":820,"NA":822},{"trials":802,"activeCount":11},[],{"trials":804,"activeCount":11},[805],{"nctId":806,"briefTitle":807,"status":58,"phases":808,"primaryCompletion":809,"completion":810,"start":811,"enrollment":812,"conditions":813,"interventions":815},"NCT04360317","Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer",[36],"2021-05","2021-08","2020-06",9,[814],"Solid Tumor",[799],{"trials":817,"activeCount":11},[],{"trials":819,"activeCount":11},[],{"trials":821,"activeCount":11},[],{"trials":823,"activeCount":11},[],{"intervention":825,"totalTrials":80,"cells":826},"SH003",{"EARLY_PHASE1":827,"PHASE1":829,"PHASE2":842,"PHASE3":844,"PHASE4":846,"NA":848},{"trials":828,"activeCount":11},[],{"trials":830,"activeCount":11},[831],{"nctId":832,"briefTitle":833,"status":95,"phases":834,"primaryCompletion":835,"completion":836,"start":837,"enrollment":838,"conditions":839,"interventions":841},"NCT03081819","A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer",[36],"2019-04-16","2019-07-25","2017-03-29",11,[840],"Solid Tumor, Adult",[825],{"trials":843,"activeCount":11},[],{"trials":845,"activeCount":11},[],{"trials":847,"activeCount":11},[],{"trials":849,"activeCount":11},[],{"intervention":851,"totalTrials":80,"cells":852},"Sipjeondaebo-tang",{"EARLY_PHASE1":853,"PHASE1":855,"PHASE2":857,"PHASE3":859,"PHASE4":861,"NA":863},{"trials":854,"activeCount":11},[],{"trials":856,"activeCount":11},[],{"trials":858,"activeCount":11},[],{"trials":860,"activeCount":11},[],{"trials":862,"activeCount":11},[],{"trials":864,"activeCount":11},[865],{"nctId":866,"briefTitle":867,"status":58,"phases":868,"primaryCompletion":869,"completion":870,"start":871,"enrollment":872,"conditions":873,"interventions":875},"NCT02858856","Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients",[40],"2018-03","2018-06","2017-03-20",48,[874],"Breast Carcinoma",[851],{"intervention":877,"totalTrials":80,"cells":878},"Euglucon 5mg",{"EARLY_PHASE1":879,"PHASE1":881,"PHASE2":883,"PHASE3":885,"PHASE4":887,"NA":889},{"trials":880,"activeCount":11},[],{"trials":882,"activeCount":11},[],{"trials":884,"activeCount":11},[],{"trials":886,"activeCount":11},[],{"trials":888,"activeCount":11},[],{"trials":890,"activeCount":11},[891],{"nctId":892,"briefTitle":893,"status":58,"phases":894,"primaryCompletion":895,"completion":896,"start":897,"enrollment":898,"conditions":899,"interventions":900},"NCT02255006","Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury",[40],"2014-10","2014-12","2014-05",36,[15],[877,901],"Celebrex 200mg",{"intervention":901,"totalTrials":80,"cells":903},{"EARLY_PHASE1":904,"PHASE1":906,"PHASE2":908,"PHASE3":910,"PHASE4":912,"NA":914},{"trials":905,"activeCount":11},[],{"trials":907,"activeCount":11},[],{"trials":909,"activeCount":11},[],{"trials":911,"activeCount":11},[],{"trials":913,"activeCount":11},[],{"trials":915,"activeCount":11},[916],{"nctId":892,"briefTitle":893,"status":58,"phases":917,"primaryCompletion":895,"completion":896,"start":897,"enrollment":898,"conditions":918,"interventions":919},[40],[15],[877,901],{"intervention":921,"totalTrials":80,"cells":922},"SJDBT",{"EARLY_PHASE1":923,"PHASE1":925,"PHASE2":927,"PHASE3":929,"PHASE4":931,"NA":933},{"trials":924,"activeCount":11},[],{"trials":926,"activeCount":11},[],{"trials":928,"activeCount":11},[],{"trials":930,"activeCount":11},[],{"trials":932,"activeCount":11},[],{"trials":934,"activeCount":11},[935],{"nctId":936,"briefTitle":937,"status":95,"phases":938,"primaryCompletion":939,"completion":940,"start":941,"enrollment":942,"conditions":943,"interventions":945},"NCT02468141","Effect of Sipjeondaebo-tang for Cancer Related Anorexia in Cancer Patients",[40],"2016-06","2016-09","2015-07",32,[944],"Cancer-related Problem\u002FCondition",[921],{"intervention":947,"totalTrials":80,"cells":948},"Capsaicin patch",{"EARLY_PHASE1":949,"PHASE1":951,"PHASE2":953,"PHASE3":955,"PHASE4":957,"NA":959},{"trials":950,"activeCount":11},[],{"trials":952,"activeCount":11},[],{"trials":954,"activeCount":11},[],{"trials":956,"activeCount":11},[],{"trials":958,"activeCount":11},[],{"trials":960,"activeCount":11},[961],{"nctId":962,"briefTitle":963,"status":58,"phases":964,"primaryCompletion":965,"completion":966,"start":967,"enrollment":448,"conditions":968,"interventions":970},"NCT01200745","Efficacy of Topical Capsaicin on Chronic Neck Pain",[40],"2011-01","2011-02","2010-09",[969],"Chronic Neck Pain",[947],{"intervention":972,"totalTrials":80,"cells":973},"flecainide",{"EARLY_PHASE1":974,"PHASE1":976,"PHASE2":978,"PHASE3":980,"PHASE4":982,"NA":984},{"trials":975,"activeCount":11},[],{"trials":977,"activeCount":11},[],{"trials":979,"activeCount":11},[],{"trials":981,"activeCount":11},[],{"trials":983,"activeCount":11},[],{"trials":985,"activeCount":11},[986],{"nctId":987,"briefTitle":988,"status":58,"phases":989,"primaryCompletion":941,"completion":941,"start":751,"enrollment":990,"conditions":991,"interventions":993},"NCT02110537","Acupuncture in Persistent Atrial Fibrillation",[40],80,[992],"Persistent Atrial Fibrillation",[972]]